Studied the genes controlling the formation of prostate and identifying what is known as the decorin team.
Existence of this gene is reduced in normal prostate cells and tumors.
Might be decorin level measurement is more reliable prostate cancer diagnostic tests now, the researchers hope.
Supplied by scientists from the reproductive health centre by United Kingdom the study of prostate cancer and the Medical Research Council (MRC) funds.
They are likely to play a role important genes, tumor growth of decorin in believe.
Lead researcher, Dr. Axel Thomson said: "which genes were active and at we prostate embryogenesis, comparing their behaviour found that prostate cancer development.
"We expected this process to shorten of the existence of one of the tumors in the prostate cells and genes - decorin - found excitement.
"Really exciting possibility suggests that normal role in the observation of decorin is to slow the growth of cancer.
'More clues'
He added: "this is the future reliable decorin level measurement of prostate cancer diagnostic tests, also or judgment may be the aggressive how illness was then, we be verification of allegations. ?
Discovery has a part of research explores the effect of environment surrounding cancer tumor growth, progress.
Dr Kate Holmes from prostate cancer United Kingdom: "development of prostate cancer research early in this species is I improve their understanding, is essential to diagnose and find ways to better treat the illness than those moving for.
"How 10000 people developed little knowledge of prostate tumors very annually losing the sick, their lives still we, grow.
"Research of this nature more important support to implementation, including these, can found more clues,"
PLOS one team's findings was published in a scientific journal.
No comments:
Post a Comment